AVROBIO Inc.

The momentum for this stock is not very good. AVROBIO Inc. is a mediocre stock to choose.

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on gene ther...

News

The Petri Dish: Curie.Bio closes $380M; Avrobio interim CEO's new gig

BizJournals.com - Nat'l Business News In this week's Petri Dish, Akebia brought on its new CFO from Cambridge's Avrobio, while Frontier Medicines has a new financial leader who was previously an investment banker and violinist.\n more…

Critical Review: AVROBIO (NASDAQ:AVRO) and Krystal Biotech (NASDAQ:KRYS)

Ticker Report AVROBIO (NASDAQ:AVRO - Get Free Report) and Krystal Biotech (NASDAQ:KRYS - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based...\n more…

AVROBIO trading halted, news pending

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Tectonic, AVROBIO complete merger, announce $130.7M private placement

Seeking Alpha - Healthcare Tectonic, AVROBIO complete merger, announce $130.7M private placement...\n more…

AVROBIO (NASDAQ:AVRO) Shares Scheduled to Reverse Split on Thursday, June 20th

Ticker Report AVROBIO, Inc. (NASDAQ:AVRO - Free Report) shares are going to reverse split before the market opens on Thursday, June 20th. The 1-12 reverse split was announced on Thursday, June 20th. The number of...\n more…

AVROBIO Stock to Reverse Split on Thursday, June 20th (NASDAQ:AVRO)

Zolmax Shares of AVROBIO, Inc. (NASDAQ:AVRO - Free Report) are set to reverse split before the market opens on Thursday, June 20th. The 1-12 reverse split was announced on Thursday, June 20th. The number of...\n more…